XtalPi Stock

xtalpi.comHealthcare / BioTech & PharmaFounded: 2016

XtalPi is a pharmaceutical technology company focused on reinventing the industry's approach to drug research and development with its Intelligent Digital Drug Discovery and Development (ID4) platform.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for XtalPi, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access XtalPi’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like XtalPi.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

XtalPi stock FAQs

plusminus

Can you buy XtalPi stock?

As XtalPi is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like XtalPi, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.
plusminus

How to buy XtalPi stock?

To invest in a private company like XtalPi through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge’s marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.
plusminus

Can you sell XtalPi stock?

Yes, you may be able to sell your XtalPi stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.
plusminus

How to sell XtalPi stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your XtalPi stock on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.
plusminus

Is XtalPi a public company?

No, XtalPi is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.
plusminus

What is XtalPi’s stock price?

XtalPi is a privately held company and therefore does not have a public stock price. However, you may access XtalPi’s private market stock price with Forge Data.
plusminus

What is XtalPi’s stock ticker symbol?

XtalPi does not have an official ticker symbol because this company is not currently publicly traded.
plusminus

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Pharmaceutical technology company XtalPi has announced a collaboration with US drug maker Eli Lilly. The partnership will focus on using AI and robotics in drug discovery, with an upfront payment of up to $250 million. XtalPi will use its ID4Inno™ small-molecule drug discovery platform, combining AI, autonomous labs, and expert domain knowledge for efficient drug discovery processes.
XtalPi has entered into a $250m partnership with Eli Lilly to utilise artificial intelligence (AI) for drug discovery. The collaboration will leverage XtalPi’s integrated AI capabilities and robotics platform to design and deliver drug candidates. The AI drug discovery solution will be used to create a novel compound, which will be advanced by Lilly through clinical and commercial development.
XtalPi, a pharmaceutical firm backed by Tencent and Softbank, plans to leverage AI to expand into materials science and discover new industrial materials. The company also intends to significantly expand its facilities in Shanghai and Hong Kong, but has no immediate plans for an IPO.
Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.